User:Mr. Ibrahem/Apalutamide

Apalutamide, sold under the brand name Erleada among others, is a medication used to treat prostate cancer. Specifically it is used in metastatic castration-sensitive prostate cancer and non-metastatic castration-resistant prostate cancer (NM-CRPC). It is taken by mouth.

Common side effects include tiredness, joint pain, rash, falls, high blood pressure, hot flashes, diarrhea, and bone fractures. Other side effects may include stroke and seizures. Use by males whose partners are pregnant may harm the baby. It is a nonsteroidal antiandrogen (NSAA) and works by blocking androgens including testosterone. As prostate cancer require androgens, blocking them slows its growth.

Apalutamide was described in 2007. It approved for medical use in the United States in 2018 and Europe in 2019. In the United Kingdom 4 weeks costs the NHS about £2,700 as of 2021. This amount in the United States is about 12,500 USD.